Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes Vitry

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Health Policy (Amsterdam, Netherlands)|June 25, 2014
Managed entry agreements for pharmaceuticals in AustraliaAgnes Vitry, Elizabeth Roughead
Journal of Pharmaceutical Policy and Practice|July 14, 2021
"Drugs to avoid" to improve quality use of medicines: how is Australia faring?Agnes Vitry, Barbara Mintzes
International Journal of Health Services : Planning, Administration, Evaluation|February 27, 2020
Access to Controlled Medicines in Low-Income Countries: Listening to Stakeholders in the FieldAgnes Vitry, Gilles Forte, Jason White
International Journal of Technology Assessment in Health Care|November 14, 2024
Evidence of clinical benefit of cancer medicines considered for funding in AustraliaAgnes Vitry, Joshua Inglis, Cathy Caird
Journal of Pharmaceutical Policy and Practice|April 9, 2016
Access to new cancer medicines in Australia: dispelling the myths and informing a public debateAgnes Vitry, Barbara Mintzes, Wendy Lipworth
Plos One|July 23, 2009
Quality of pharmaceutical advertisements in medical journals: a systematic reviewNoordin Othman, Agnes Vitry, Elizabeth E Roughead
Peerj|October 27, 2021
Evaluating changes in student health, wellbeing and social circumstances before and during COVID-19 pandemic restrictions in AustraliaDannielle Post, Agnes Vitry, Katherine L Baldock
International Journal of Health Services : Planning, Administration, Evaluation|December 13, 2007
Is Australia's national medicines policy failing? The case of COX-2 inhibitorsAgnes Vitry, Joel Lexchin, Peter R Mansfield
Cancer Epidemiology|September 6, 2022
Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosisKazzem Gheybi, Elizabeth Buckley, Agnes Vitry, et al.
Cancer Medicine|April 21, 2023
Variations in colorectal cancer pattern of care by age and comorbidity in South AustraliaKazzem Gheybi, Elizabeth Buckley, Agnes Vitry, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Health Policy (Amsterdam, Netherlands)|June 25, 2014
Managed entry agreements for pharmaceuticals in AustraliaAgnes Vitry, Elizabeth Roughead
Journal of Pharmaceutical Policy and Practice|July 14, 2021
"Drugs to avoid" to improve quality use of medicines: how is Australia faring?Agnes Vitry, Barbara Mintzes
International Journal of Health Services : Planning, Administration, Evaluation|February 27, 2020
Access to Controlled Medicines in Low-Income Countries: Listening to Stakeholders in the FieldAgnes Vitry, Gilles Forte, Jason White
International Journal of Technology Assessment in Health Care|November 14, 2024
Evidence of clinical benefit of cancer medicines considered for funding in AustraliaAgnes Vitry, Joshua Inglis, Cathy Caird
Journal of Pharmaceutical Policy and Practice|April 9, 2016
Access to new cancer medicines in Australia: dispelling the myths and informing a public debateAgnes Vitry, Barbara Mintzes, Wendy Lipworth
Plos One|July 23, 2009
Quality of pharmaceutical advertisements in medical journals: a systematic reviewNoordin Othman, Agnes Vitry, Elizabeth E Roughead
Peerj|October 27, 2021
Evaluating changes in student health, wellbeing and social circumstances before and during COVID-19 pandemic restrictions in AustraliaDannielle Post, Agnes Vitry, Katherine L Baldock
International Journal of Health Services : Planning, Administration, Evaluation|December 13, 2007
Is Australia's national medicines policy failing? The case of COX-2 inhibitorsAgnes Vitry, Joel Lexchin, Peter R Mansfield
Cancer Epidemiology|September 6, 2022
Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosisKazzem Gheybi, Elizabeth Buckley, Agnes Vitry, et al.
Cancer Medicine|April 21, 2023
Variations in colorectal cancer pattern of care by age and comorbidity in South AustraliaKazzem Gheybi, Elizabeth Buckley, Agnes Vitry, et al.
Pageof 4